Our Treatment Experience

Cord blood stem cells are playing a major role in transplant medicine, an innovative therapeutic approach to treating disease. ViaCord has helped more families utilize the healing power of their cord blood stem cells . To date, we have preserved the cord blood of more than 350,000 newborns and released more cord blood units to doctors and researchers — 300+ — than any other family bank.1 , 5  

Every cell counts.

Just as important as the depth of our experience is the proven quality of our stem cell collections. From collection to cryopreservation, our complete process is designed to maximize stem cell yield, which directly correlates with treatment success. The more stem cells that transplant doctors have to work with, the better the outcome for their patients. We've released 300+ stem cell collections for use in treatment and clinical trials to date. See our Transplant & Infusions list for details.

An unmatched track record.

Nearly 90% of the medical treatments that utilized cord blood stem cells prepared by ViaCord have been successful - the highest rate shared by any family bank.9 We believe in the importance of publishing treatment success rates. After all, should you ever need to use your child’s stem cell collection, a healthy outcome is what matters most.

Dr. Mark Walters says...

"Our experience in umbilical cord blood transplantation has shown definitively that the single most important factor in ensuring a successful curative outcome is the number of cells that are infused at transplantation."

-  Mark Walters, MD 

Pediatric Hematologist/Oncologist, Children's Hospital Oakland, CA

Medical Director, ViaCord

Cord Blood In Action

When baby Harlow was just four months old, she was diagnosed with an aggressive form of cancer. Because her parents, Jamie and Ben, had banked her cord blood with ViaCord, doctors were able to treat Harlow’s cancer with the help of her very own stem cells.